共 50 条
- [42] Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19 CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (03): : 1133 - 1146
- [43] Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (04): : 410 - 424
- [48] How New Mexico Leveraged a COVID-19 Case Forecasting Model to Preemptively Address the Health Care Needs of the State: Quantitative Analysis JMIR PUBLIC HEALTH AND SURVEILLANCE, 2021, 7 (06):
- [49] Effects of four types of integrated Chinese and Western medicines for the treatment of COVID-19 in China: a network meta-analysis REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (06): : 771 - 777
- [50] Towards the discovery of potential RdRp inhibitors for the treatment of COVID-19: structure guided virtual screening, computational ADME and molecular dynamics study Structural Chemistry, 2022, 33 : 1569 - 1583